Non-sterile type can be sterilized by autoclave! Integrity testing can also be performed before and after use.
The "Acro 50 Vent Filter" is designed as a bacterial air vent for the sterilization of air and gases, as well as for pharmaceutical research and experimental processes. The filter's pore sizes are available in three options: 0.2, 0.45, and 1 μm. Additionally, we offer the "Acro 50 Bend Device (Enflon II PVDF Membrane)" which has a removal rate of 0.2 μm in liquids and can remove particles smaller than 0.02 μm in air/gas applications. 【Features of PTFE Membrane】 ■ The filter's pore sizes are available in three options: 0.2, 0.45, and 1 μm ■ Non-sterile type that can be sterilized by autoclaving ■ Integrity testing can be performed before and after use ■ Filters are available with hose barb, 1/8 inch MNPT, and 3/8 inch straight pipe options *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Enflon II PVDF Membrane Features】 ■ The filter is resistant to 50 kGy of gamma radiation. ■ Removal rate of 0.2 μm in liquids. ■ Capable of removing particles smaller than 0.02 μm in air/gas applications. ■ Checks the ability to capture bacteria to ensure sterilization of air and gas. *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.